We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COO icon
26
Cooper Companies
COO
$14.6B
$142M 0.88%
1,680,716
+899,376
+115% +$67.6M
TMO icon
27
Thermo Fisher Scientific
TMO
$214B
$139M 0.87%
474,946
+166,927
+54% +$46M
GPN icon
28
Global Payments
GPN
$23.9B
$138M 0.86%
860,808
+8,110
+1% +$1.21M
CSL icon
29
Carlisle Companies
CSL
$15.3B
$133M 0.83%
947,374
-280,517
-23% -$37.7M
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.43T
$125M 0.77%
2,301,180
-1,635,940
-42% -$94.7M
AZN icon
31
AstraZeneca
AZN
$250B
$124M 0.77%
1,506,825
+1,449,499
+2,529% +$114M
BKNG icon
32
Booking.com
BKNG
$160B
$120M 0.75%
1,604,350
+1,322,175
+469% +$95M
AVY icon
33
Avery Dennison
AVY
$13.4B
$119M 0.74%
1,031,090
+531,517
+106% +$58.2M
MCD icon
34
McDonald's
MCD
$195B
$117M 0.73%
564,506
+240,056
+74% +$47.5M
PNR icon
35
Pentair
PNR
$11B
$117M 0.72%
3,139,107
+3,042,541
+3,151% +$115M
GDDY icon
36
GoDaddy
GDDY
$11.6B
$117M 0.72%
1,661,055
-182,512
-10% -$13.8M
FISV
37
Fiserv Inc
FISV
$28.9B
$112M 0.7%
1,228,786
-125,699
-9% -$11M
SNPS icon
38
Synopsys
SNPS
$76.7B
$103M 0.64%
801,668
+255,451
+47% +$30.7M
MU icon
39
Micron Technology
MU
$1.01T
$101M 0.63%
2,621,007
+2,385,807
+1,014% +$90.9M
PYPL icon
40
PayPal
PYPL
$49.6B
$101M 0.63%
881,248
+167,556
+23% +$18.6M
ASND icon
41
Ascendis Pharma A/S
ASND
$16B
$101M 0.62%
873,645
-287,831
-25% -$34.4M
UHS icon
42
Universal Health Services
UHS
$10.4B
$98.7M 0.61%
756,805
+13,811
+2% +$1.74M
PODD icon
43
Insulet
PODD
$9.23B
$87.5M 0.54%
+732,796
New +$75.1M
INTU icon
44
Intuit
INTU
$89.7B
$86.8M 0.54%
332,109
-89,614
-21% -$22.8M
NSC icon
45
Norfolk Southern
NSC
$76.8B
$84.1M 0.52%
421,884
+47,431
+13% +$9.41M
FOLD
46
DELISTED
Amicus Therapeutics
FOLD
$83.7M 0.52%
6,708,228
+278,209
+4% +$3.53M
CSGP icon
47
CoStar Group
CSGP
$12.2B
$83.3M 0.52%
1,503,490
-708,670
-32% -$36.2M
KO icon
48
Coca-Cola
KO
$374B
$81.4M 0.51%
1,598,775
+1,575,559
+6,787% +$77.2M
GWPH
49
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$80.3M 0.5%
466,062
+149,163
+47% +$25.8M
WP
50
DELISTED
Worldpay, Inc.
WP
$79.2M 0.49%
646,583
+116,050
+22% +$13.8M
1
2
3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.